OVA Conjugated Neurofilament, Light Polypeptide (NEFL) 
CMT1F; CMT2E; NF-L; NF68; NFL; 68 kDa neurofilament protein; Neurofilament triplet L protein
Overview
Properties
- Product No.CPE038Hu21
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
-
Applications
Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
Research use only - DownloadInstruction Manual
- CategoryNeuro science
- SourceProtein Conjugation
- Original Molecular Massn/a
- Buffer FormulationPBS, pH7.4.
- Traits Freeze-dried powder, Purity > 90%
- Isoelectric Pointn/a
Share your citation
Upload your experimental result
Review
Leave a message
Loading...
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Please attach serial No. on instruction manual
Contact us
Please fill in the blank.
Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code*
-
Packages (Simulation)
-
Packages (Simulation)
-
Mass spectrometry
-
-
ISO9001: 2008, ISO13485: 2003 Registered
Formula
Usage
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Increment services
Citations
- Effect of carotid endarterectomy on brain damage markersPubmed:27126899
- Effect of carotid endarterectomy on brain damage markers.pubmed:27126899
- Cytokines and biological markers in autoimmune GFAP astrocytopathy: The potential role for pathogenesis and therapeutic implicationsPubmed: 31254929
- Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia33893614
- Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis34678870
- Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients …Pubmed:35566558